Photo from Yüksel Ürün/X
Mar 9, 2024, 12:51
Yüksel Ürün: Important information for lung cancer patients taking TKIs
Yüksel Ürün, Professor of medicine in the Department of Medical Oncology of Ankara University School of Medicine, Turkey, shared a post on X:
“Important information for lung cancer patients taking TKIs (tyrosine kinase inhibitor)
Lung cancer patients taking both PPIs (proton pump inhibitor) and certain TKIs may have higher risk of death!
New study finds drug drug interaction reduces drug effectiveness.
Avoid unnecessary drug use!”
Read further.
Source: Yüksel Ürün/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 19, 2024, 10:18
Nov 19, 2024, 10:05
Nov 19, 2024, 09:53
Nov 19, 2024, 09:44
Nov 19, 2024, 09:40
Nov 19, 2024, 09:28